Commercial Launch Of COVID-19 Treatments To Start November 1

The AP (10/27, Seitz) reported COVID treatments, which are no longer covered by the government, “will enter the private market [this] week with a hefty price tag.” Pfizer is pricing a five-day course of Paxlovid (nirmatrelvir/ritonavir) “at $1,390, but Am...